Webinar - Coordinated Development of Antimicrobial Drugs and Antimicrobial Susceptibility Test Devices - February 12, 2019
February 12, 2019
- February 12, 2019
- Organized By:
On Tuesday, February 12, 2019, the U.S. Food and Drug Administration (FDA) will host a webinar on the final guidance, “Coordinated Development of Antimicrobial Drugs and Antimicrobial Susceptibility Test Devices.” The goal of this guidance is to minimize time between the approval of new antimicrobial drugs and clearance of antimicrobial susceptibility tests for those drugs and to provide recommendations to the medical device and drug industry on how to work together to facilitate timely antimicrobial susceptibility test device clearance by the FDA. This final guidance supports the FDA’s strategic approach for combatting antimicrobial resistance to better coordinate drug and device development, promote stewardship, support antimicrobial resistance surveillance and advance regulatory science.